[Predementia neurocognitive impairment in the elderly]

Area of Science:

• Neurology
• Gerontology
• Cognitive Science

Background:

• Cognitive decline is a primary indicator of brain damage, particularly in the elderly.
• Distinguishing between normal aging, mild cognitive impairment (MCI), and severe dementia is critical for patient care.
• MCI is recognized as a prodromal phase of dementia, bridging normal aging and significant cognitive impairment.

Purpose of the Study:

• To explore the concept of mild cognitive impairment (MCI) as a distinct clinical entity.
• To understand the significance of pre-MCI and overlapping syndromes in the spectrum of cognitive decline.
• To inform clinical trial design and patient management strategies for individuals with MCI and pre-MCI.

Main Methods:

• Review of existing literature on cognitive decline and aging.
• Analysis of the diagnostic criteria and implications of mild cognitive impairment (MCI).
• Examination of the relationship between MCI, normal aging, and dementia.

Main Results:

• Mild cognitive impairment (MCI) represents a prolonged intermediate stage of cognitive deficit.
• MCI does not reach the severity of dementia but exceeds normal age-related changes.
• The identification of MCI and related syndromes has significant theoretical and practical implications.

Conclusions:

• Mild cognitive impairment (MCI) is an integral part of a complex structure of overlapping syndromes.
• Accurate classification of MCI and pre-MCI syndromes is essential for targeted therapeutic strategies.
• Rational management approaches for patients with MCI and pre-MCI can be developed based on current understanding.